National Health Investors Inc
NYSE:NHI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
51.62
85.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
National Health Investors Inc
Wall Street
Price Targets
NHI Price Targets Summary
National Health Investors Inc
According to Wall Street analysts, the average 1-year price target for
NHI
is 87.57 USD
with a low forecast of 76.76 USD and a high forecast of 96.6 USD.
NHI Last Price Targets
National Health Investors Inc
The latest public price target was made on Sep 24, 2024 by
Joshua Dennerlein
from
Bank of America Securities
,
who expects
NHI
stock to
rise by 18%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Joshua Dennerlein
Bank of America Securities
|
92
USD
Upside 18% |
1 month ago
Sep 24, 2024
|
BofA Securities Starts National Health Investors (NHI) at Buy
StreetInsider
|
Michael Lewis
Truist Financial
|
78
USD
Downside 0% |
2 months ago
Aug 30, 2024
|
National Health Investors price target raised to $78 from $65 at Truist
TheFly
|
|
Michael Lewis
Truist Financial
|
58
USD
Downside 26% |
7 months ago
Apr 3, 2024
|
National Health Investors (NHI) PT Raised to $58 at Truist Securities
StreetInsider
|
|
John Kim
National Bank
|
67
USD
Downside 14% |
8 months ago
Mar 12, 2024
|
BMO Capital Upgrades National Health Investors (NHI) to Outperform, 'Turning the Corner & Finally Hitting Its Stride'
StreetInsider
|
Connor Siversky
Wells Fargo
|
63
USD
Downside 19% |
8 months ago
Feb 26, 2024
|
Wells Fargo Upgrades National Health Investors (NHI) to Overweight
StreetInsider
|
Operating Income
Forecast
Operating Income Estimate
National Health Investors Inc
For the last 8 years the
compound annual growth rate for
National Health Investors Inc's operating income is
1%.
The projected
CAGR
for the next 3 years is
8%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NHI's stock price target?
Price Target
87.57
USD
According to Wall Street analysts, the average 1-year price target for
NHI
is 87.57 USD
with a low forecast of 76.76 USD and a high forecast of 96.6 USD.
What is National Health Investors Inc's Revenue forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
National Health Investors Inc's revenue is
4%.
The projected
CAGR
for the next 3 years is
12%.
What is National Health Investors Inc's Operating Income forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
National Health Investors Inc's operating income is
1%.
The projected
CAGR
for the next 3 years is
8%.
What is National Health Investors Inc's Net Income forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
National Health Investors Inc's net income is
-1%.
The projected
CAGR
for the next 3 years is
4%.
You don't have any saved screeners yet
